Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | NNMT | P40261 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 3/20 | 0.37 |
| ▸ | IKBKB | O14920 | 1/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | PLK4 | O00444 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30733977 | 0.80 | DGAT1 (0.42) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL975196 | 0.79 | CYP1A2 (0.46) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL4883745 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL3633773 | 0.74 | P2RX7 (0.40) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL6616377 | 0.72 | BCAT2 (0.47) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL3632864 | 0.71 | CASP1 (0.36) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL11583311 | 0.70 | CHUK (0.37) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL3424158 | 0.69 | ERN1 (0.54) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL30211643 | 0.69 | ERN1 (0.54) | KDM4EALDH1A1MAPTHPGDTSHR | |
| SCHEMBL7242650 | 0.69 | NPC1 (0.49) | KDM4EALDH1A1MAPTHPGDTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112006967-A | Anti-aging composition for cosmetics and preparation method thereof | 张虎 | 2020-12-01 | — | — | CN | claimed |
| CN-116023654-A | Resin for transparent copolymerized nylon film and film forming process thereof | 中国石油化工股份有限公司 | 2023-04-28 | — | — | CN | disclosed |
| WO-2022178846-A1 | REUSABLE MULTIFUNCTIONAL NANO-SURFACTANT AND PREPARATION METHOD THEREFOR | 中国科学院生态环境研究中心 | 2022-09-01 | — | — | WO | disclosed |
| CN-112980595-B | Recyclable multifunctional nano surfactant and preparation method thereof | 中国科学院生态环境研究中心 | 2022-03-18 | — | — | CN | disclosed |
| CN-112980595-A | Recyclable multifunctional nano surfactant and preparation method thereof | 中国科学院生态环境研究中心 | 2021-06-18 | — | — | CN | disclosed |
| CN-112006967-A | Anti-aging composition for cosmetics and preparation method thereof | 张虎 | 2020-12-01 | — | — | CN | disclosed |
| US-9499570-B2 | Boron containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-9499570-B2 | Boron containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-9499570-B2 | Boron containing small molecules | ANACOR PHARMACEUTICALS, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-20150376210-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, LLC | 2015-12-31 | — | — | US | disclosed |
| US-20120035132-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035132-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2012-02-09 | — | — | US | disclosed |
| US-20120035132-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC. (US) | 2012-02-09 | — | — | US | disclosed |
| WO-2011094450-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011094450-A1 | BORON-CONTAINING SMALL MOLECULES | ANACOR PHARMACEUTICALS, INC (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2000006547-A1 | PROCESS FOR THE PREPARATION OF 2,6-DICHLORONICOTINONITRILES | ASAHI GLASS COMPANY LTD. (JP) | 2000-02-10 | — | — | WO | disclosed |
| US-5155113-A | Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-10-13 | — | — | US | disclosed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | disclosed |
| EP-0180188-A2 | A composition for increasing the anti-cancer activity of an anti-cancer compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1986-05-07 | — | — | EP | disclosed |
| US-4079052-A | Diazopigments containing pyridine derivatives | CIBA-GEIGY CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035132-A1 | BORON-CONTAINING SMALL MOLECULES | BTD, BCL6B, BBOX1 | KDM4E 3959/4885ALDH1A1 3735/4885MAPT 2053/4885 |
| US-20150376210-A1 | BORON-CONTAINING SMALL MOLECULES | BTD, BCL6B, BBOX1 | KDM4E 3959/4885ALDH1A1 3735/4885MAPT 2053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.